Bill Commons

CA AB 2489

in committee

Controlled substances: research.

California · 2025-2026 Regular Session · lower

Description

Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances in Schedule V. Existing law creates the Research Advisory Panel, as specified, to conduct hearings on, and in other ways study, research projects concerning controlled substances. Existing law authorizes the panel to approve research projects that have been registered with the Attorney General concerning the nature and effects of cannabis or hallucinogenic drugs and the treatment of abuse of controlled substances. Existing law authorizes a person who, under federal law, is entitled to use controlled substances for the purpose of research, instruction, or analysis to lawfully obtain and use those controlled substances upon approval by the panel, as specified. This bill, the California Veterans' Right to Try Act, would, until January 1, 2032, authorize the Research Advisory Panel to submit an investigational new drug application to the United States Food and Drug Administration requesting approval for a clinical trial of Schedule I or Schedule II controlled substances to study the administration and efficacy of those compounds among a patient pool comprised exclusively of veteran subjects with comorbidities that commonly overlap with the incidence of suicidality among veterans. This bill would make technical changes and would make related findings and declarations.

Introduced
2026-04-08
Status date
—
Latest action
2026-05-14 — In committee: Held under submission.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Lowenthalauthor
  • Jeff Gonzalezprincipal coauthor
  • Harabediancoauthor
  • Pattersoncoauthor

Committees

Not provided by source.

Action timeline

  1. 2026-02-20

    Read first time. To print.

    reading-1

  2. 2026-02-21

    From printer. May be heard in committee March 23.

  3. 2026-03-09

    Referred to Coms. on HEALTH and M. & V.A.

    referral-committee

  4. 2026-04-08

    From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 16. Noes 0.) (April 7).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  5. 2026-04-09

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  6. 2026-04-13

    Re-referred to Com. on APPR.

    referral-committee

  7. 2026-04-29

    In committee: Set, first hearing. Referred to APPR. suspense file.

    referral-committee

  8. 2026-05-14

    Coauthors revised.

  9. 2026-05-14

    In committee: Held under submission.

Versions

Documents

Votes

  • Do pass as amended and be re-referred to the Committee on [Appropriations]

    2026-04-07 · pass · 16-0

    Member-level votes (16)
    • Aguiar-Curry: yes
    • Patterson: yes
    • Rogers: yes
    • Schiavo: yes
    • Mark González: yes
    • Stefani: yes
    • Chen: yes
    • Bonta: yes
    • Carrillo: yes
    • Sanchez: yes
    • Caloza: yes
    • Addis: yes
    • Ahrens: yes
    • Sharp-Collins: yes
    • Johnson: yes
    • Patel: yes

Related bills

No related bills recorded for this bill.

Official source

http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB2489

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 2489. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.